Literature DB >> 19150424

Baxbeta: a constitutively active human Bax isoform that is under tight regulatory control by the proteasomal degradation mechanism.

Nai Yang Fu1, Sunil K Sukumaran, Sze Yen Kerk, Victor C Yu.   

Abstract

Although mRNAs of multiple isoforms of Bax, which encodes a central regulator of apoptosis signaling, have been reported, only Baxalpha protein has been well documented and studied. Baxalpha exists in latent form and is activated upon apoptosis induction through conformational changes. Here we demonstrate that Baxbeta protein is ubiquitously present among human cells, but its activity is restricted through stringent regulation by proteasomal degradation. In contrast to Baxalpha, native Baxbeta spontaneously integrates into mitochondrial membrane and is highly potent in inducing cytochrome c release from mitochondria. Remarkably, Baxbeta protein is upregulated by apoptotic stimuli via inhibition of its ubiquitination process, and stable expression of Baxbeta in HCT116-Bax(-/-) cells restores their sensitivity to multiple stimuli. Baxbeta associates with and promotes Baxalpha activation. Moreover, selective knockdown of Baxbeta desensitizes HCT116-Bax(+/-) cells to Bax-dependent apoptosis signaling. These observations underscore the plasticity of human Bax in serving its role as a "gatekeeper" for apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19150424     DOI: 10.1016/j.molcel.2008.11.025

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  34 in total

1.  Stemming danger with Golgified BAX.

Authors:  Loren D Walensky
Journal:  Mol Cell       Date:  2012-06-08       Impact factor: 17.970

2.  IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for Bax and apoptosis activation.

Authors:  Giovanni Benard; Albert Neutzner; Guihong Peng; Chunxin Wang; Ferenc Livak; Richard J Youle; Mariusz Karbowski
Journal:  EMBO J       Date:  2010-03-18       Impact factor: 11.598

Review 3.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

4.  BH3-triggered structural reorganization drives the activation of proapoptotic BAX.

Authors:  Evripidis Gavathiotis; Denis E Reyna; Marguerite L Davis; Gregory H Bird; Loren D Walensky
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

Review 5.  Mitochondrial control of caspase-dependent and -independent cell death.

Authors:  Ludivine A Pradelli; Marie Bénéteau; Jean-Ehrland Ricci
Journal:  Cell Mol Life Sci       Date:  2010-02-12       Impact factor: 9.261

6.  The functional domains for Bax∆2 aggregate-mediated caspase 8-dependent cell death.

Authors:  Adriana Mañas; Sheng Wang; Adam Nelson; Jiajun Li; Yu Zhao; Huaiyuan Zhang; Aislinn Davis; Bingqing Xie; Natalia Maltsev; Jialing Xiang
Journal:  Exp Cell Res       Date:  2017-08-12       Impact factor: 3.905

Review 7.  When one becomes many-Alternative splicing in β-cell function and failure.

Authors:  Maria Inês Alvelos; Jonàs Juan-Mateu; Maikel Luis Colli; Jean-Valéry Turatsinze; Décio L Eizirik
Journal:  Diabetes Obes Metab       Date:  2018-09       Impact factor: 6.577

Review 8.  Intrinsically disordered proteins in bcl-2 regulated apoptosis.

Authors:  Gilles J P Rautureau; Catherine L Day; Mark G Hinds
Journal:  Int J Mol Sci       Date:  2010-04-16       Impact factor: 5.923

9.  Involvement of p63 in the herpes simplex virus-1-induced demise of corneal cells.

Authors:  László Orosz; Eva Gallyas; Lajos Kemény; Yvette Mándi; Andrea Facskó; Klára Megyeri
Journal:  J Biomed Sci       Date:  2010-06-07       Impact factor: 8.410

10.  Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer.

Authors:  A R Garcia-Rendueles; J S Rodrigues; M E R Garcia-Rendueles; M Suarez-Fariña; S Perez-Romero; F Barreiro; I Bernabeu; J Rodriguez-Garcia; L Fugazzola; T Sakai; F Liu; J Cameselle-Teijeiro; S B Bravo; C V Alvarez
Journal:  Oncogene       Date:  2016-07-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.